Poliovirus vaccine live oral - Birmex

Drug Profile

Poliovirus vaccine live oral - Birmex

Alternative Names: Trivalent OPV Birmex

Latest Information Update: 24 Feb 2016

Price : $50

At a glance

  • Originator Birmex
  • Class Viral vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Poliomyelitis

Most Recent Events

  • 08 Aug 2013 Phase-III clinical trials in Poliomyelitis (in neonates, prevention) in Mexico (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top